关于召开2025年第四次临时股东会的通知 证券代码：600568 证券简称：ST 中珠 公告编号：2025-069 号 中珠医疗控股股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、召开会议的基本情况 2025年第四次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 12 月 25 日 10 点 00 分 召开地点：珠海市情侣南路 1 号仁恒滨海中心 5 座 8 层 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 25 日 至2025 年 12 月 25 日 (一)股东会类型和届次 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互 联网投票平台的投票时间为 ...

第十届董事会第十四次会议决议公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 1、中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）第十 届董事会第十四次会议的召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 证券代码：600568 证券简称：ST 中珠 公告编号：2025-067 号 中珠医疗控股股份有限公司 具体内容详见公司同日披露的《中珠医疗控股股份有限公司关于股东提名 非独立董事候选人、独立董事候选人的公告》（公告编号：2025-068 号）。 （二）审议通过《关于补选公司第十届董事会独立董事候选人的议案》； 表决结果：同意 8 票，反对 0 票，弃权 0 票。 2、本次董事会会议于 2025 年 12 月 5 日以邮件、电话、微信送达方式发出 通知。 3、本次董事会会议于 2025 年 12 月 9 日以通讯会议的方式召开。 4、本次董事会会议应出席董事 8 人，实际出席董事 8 人。 二、董事会会议审议情况 经与会董事认真审议，通过以下议案： （ ...

New Stock Issuance - New stocks issued include 纳百川 (code: 301667) at an issuance price of 22.63 and 优迅股份 (code: 787807) at 51.66[1] Rights Issues and Announcements - 荃银高科 (code: 300087) has a tender offer period from December 4, 2025, to January 5, 2026[1] - 天普股份 (code: 605255) has a tender offer period from November 20, 2025, to December 19, 2025[1] Delisting and Special Notices - *ST广道 (code: 920680) will enter the delisting arrangement period starting December 11, 2025[1] - *ST苏吴 (code: 600200) will enter the delisting arrangement period starting December 9, 2025[1] Stock Performance Alerts - 赛微电子 (code: 300456) reported severe abnormal fluctuations[1] - 海王生物 (code: 000078) and 瑞达期货 (code: 002961) also reported significant fluctuations[1] Additional Stock Announcements - 航天发展 (code: 000547) and 顺灏股份 (code: 002565) have issued announcements regarding their stock performance[1]

证券之星消息，12月5日医疗服务板块较上一交易日下跌0.03%，ST中珠领跌。当日上证指数报收于 3902.81，上涨0.7%。深证成指报收于13147.68，上涨1.08%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600721 | 自花医药 | 10.77 | 10.01% | 51.19万 | 5.31亿 | | 920670 | 数字人 | 15.35 | 3.23% | 3.19万 | 4843.18万 | | 688710 | 益诺思 | 41.99 | 2.89% | 1.38万 | 5757.13万 | | 301096 | 百诚医药 | 54.49 | 2.48% | 2.61万 | 1.41亿 | | 301267 | 华屋眼科 | 18.90 | 2.27% | 6.22万 | 1.17亿 | | 002622 | 皓宸医疗 | 3.37 | 2.12% | 19.61万 | 6549.95万 | | 002173 | 创新医疗 | 22 ...

Market Performance - Major market indices opened with mixed results, with the Shanghai Composite Index down 0.07% at 3873.12 points, the Shenzhen Component Index up 0.10% at 13020.29 points, and the ChiNext Index up 0.55% at 3084.22 points [1] Individual Stock Performance - A total of 1920 stocks rose at the open, with newly listed stock N Moer-U surging 468.78% at the opening [1] - There were 4 stocks hitting the daily limit up, including Gaole Shares with 5 consecutive limit ups, Junya Technology with 3 consecutive limit ups, and Longzhou Shares with 3 consecutive limit ups [1] - Conversely, 2381 stocks declined at the open, with 6 stocks hitting the daily limit down, including *ST Aowei and *ST Fanli [1] Price Continuity Statistics - Among stocks that hit the limit up yesterday, Longzhou Shares and Gaole Shares continued to hit the limit up today [1] - Stocks that opened lower included Guga Technology, Zhongzai Zihuan, and ST Zhongzhu, with declines of 6.36%, 3.52%, and 2.70% respectively [1] - Among stocks that hit the limit down yesterday, 6 stocks continued to hit the limit down today, including *ST Aowei and *ST Fanli, while stocks that opened higher included Guofeng New Materials, *ST Yanshi, and Hainan Ruize, with increases of 4.70%, 2.61%, and 0.87% respectively [1]

近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.12.03 | -4.41 | 4.72 | -2863.13 | | 2025.12.02 | 3.51 | 7.62 | -3879.09 | | 2025.12.01 | 5.17 | 1.38 | 33.52 | | 2025.11.28 | 5.04 | 4.54 | 1866.57 | | 2025.11.27 | -4.44 | 9.03 | -6825.52 | | 2025.11.26 | 5.06 | 5.12 | -844.61 | | 2025.11.25 | 4.90 | 0.32 | 552.16 | | 2025.11.24 | 5.15 | 3.80 | 540.69 | | 2025.11.21 | 2.19 | 2.95 | -433.17 | | 2025.11.20 | 0.88 | 2.21 | 0.68 | （文章来源：证券时报网） 龙虎榜数据显示，该股因连续三个交易日内，收盘价涨幅偏离值累计达到12%的S ...

证券代码：600568 证券简称：ST 中珠 公告编号：2025-066 号 中珠医疗控股股份有限公司 股票交易异常波动的公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）股票于2025 年11月28日、12月1日、12月2日连续三个交易日内日收盘价格涨幅偏离值累计达到12%， 根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 其他风险警示的风险：截至2024年度期末，因珠海中珠集团股份有限公司及其 关联方资金占用问题尚未解决，公司股票继续被实施其他风险警示。 业绩亏损的风险：截至本公告披露日，公司最近连续三个会计年度归属于上市 公司股东的扣除非经常性损益后的净利润均为负值。2024年度，归属于上市公司股东 的扣除非经常性损益的净利润-62,386.69万元。 业绩承诺兑现的风险：因深圳市一体医疗科技有限公司2017年度未完成承诺业 绩，补偿方深圳市一体投资控股集团有限公司、深圳市一体正润资产管理有限公司（已 更名深圳市 ...

Core Viewpoint - ST Zhongzhu's stock experienced a significant price fluctuation, with a cumulative increase of 12% over three consecutive trading days, prompting an announcement regarding abnormal trading conditions [1] Group 1: Stock Performance and Trading Conditions - The stock price deviation reached a cumulative increase of 12% over the trading days of November 28, December 1, and December 2, 2025, which is classified as abnormal trading behavior according to Shanghai Stock Exchange regulations [1] - The company conducted a self-examination and confirmed with its largest shareholder, Shenzhen Landi Technology Development Co., Ltd., that there are no undisclosed significant information affecting stock price fluctuations [1] Group 2: Shareholder Actions and Agreements - Shareholders holding more than 5% of the company's stock, Guangzhou Yunying Capital Management Co., Ltd. and Zheng Zixian, signed a share transfer agreement with Gongqingcheng Meihua Tenglong Qifei Investment Partnership to transfer a total of 10.38% of the company's shares, although this transfer has not yet been completed [1] - The controlling shareholder of the largest shareholder, Shenzhen Shenshang Holding Group Co., Ltd., plans to transfer 100% of its stake in Landi Technology to Suzhou Bubugao Investment Development Co., Ltd., which is also pending completion [1] Group 3: Financial Performance and Risks - As of the end of the 2024 fiscal year, the company continues to face risk warnings due to fund occupation issues, with net profits for the last three accounting years (excluding non-recurring gains and losses) being negative, amounting to -62.39 million yuan for 2024 [1] - The company holds a total debt claim of 313.34 million yuan against Shenzhen Yiti Medical Technology Co., Ltd., which has not fulfilled its performance commitments since 2017, and the compensation party has not fully met its obligations, with only 4.04 million yuan recovered to date [1] - As of the end of 2024, the balance of fund occupation by Zhuhai Zhongzhu Group Co., Ltd. and its related parties is 56.80 million yuan, and the company has initiated legal proceedings for recovery and applied for compulsory enforcement, although some repayment commitments remain unfulfilled [1]

关于下属公司收到民事裁定书的公告 特别提示 证券代码：600568 证券简称：ST 中珠 公告编号：2025-065 号 中珠医疗控股股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）下属深圳 市一体医疗科技有限公司（以下简称"一体医疗"）于 2025 年 11 月 29 日收到河 南省濮阳市中级人民法院（以下简称"濮阳中院"）出具的《民事裁定书》（（2025） 豫 09 民终 1336 号），因一体医疗与濮阳市第五人民医院（以下简称"濮阳五院"） 合同纠纷一案，濮阳中院已做出二审判决。具体内容如下： 一、本次诉讼的基本情况 2015 年 11 月 30 日，一体医疗与被告濮阳五院签订了《关于共同成立肿瘤 诊疗中心的合作协议》双方约定成立濮阳市第五人民医院"肿瘤诊疗中心"，自 主经营，自负盈亏，医院统一收费，独立核算。在合作过程中，濮阳五院未按双 方约定支付回购款，经一体医疗多次催促仍未支付。 为维护一体医疗的合法权益，一体医疗向河南省濮阳市 ...

Market Overview - On December 1, the medical services sector rose by 0.68% compared to the previous trading day, with ST Zhongzhu leading the gains [1] - The Shanghai Composite Index closed at 3914.01, up 0.65%, while the Shenzhen Component Index closed at 13146.72, up 1.25% [1] Top Gainers in Medical Services Sector - ST Zhongzhu (600568) closed at 2.85, up 5.17% with a trading volume of 230,800 shares and a turnover of 64.91 million yuan [1] - Haoyuan Pharmaceutical (688131) closed at 78.45, up 3.21% with a trading volume of 30,400 shares and a turnover of 238 million yuan [1] - Kanglong Chemical (300759) closed at 29.66, up 2.45% with a trading volume of 189,900 shares and a turnover of 563 million yuan [1] Top Losers in Medical Services Sector - Bid Pharma (688073) closed at 69.33, down 4.70% with a trading volume of 10,800 shares and a turnover of 75.39 million yuan [2] - Chengda Pharmaceutical (301201) closed at 45.90, down 4.26% with a trading volume of 116,700 shares [2] - Yaokang Bio (688046) closed at 16.40, down 4.21% with a trading volume of 36,600 shares and a turnover of 60.80 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 152 million yuan from institutional investors, while retail investors saw a net inflow of 88.82 million yuan [2] - Notable stocks with significant capital inflow include Innovation Medical (002173) with a net inflow of 29.99 million yuan from institutional investors [3] - Conversely, stocks like Bid Pharma (688073) faced a net outflow of 63.70 million yuan from institutional investors [3]